Open Access iconOpen Access

REVIEW

Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring

EFFAT ALEMZADEH1, LEILA ALLAHQOLI2, HAMIDEH DEHGHAN3, AFROOZ MAZIDIMORADI4, ALIREZA GHASEMPOUR3, HAMID SALEHINIYA5,*

1 Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, 9717853577, Iran
2 Midwifery Department, Ministry of Health and Medical Education, Tehran, 9413933336, Iran
3 Student Research Committee, Birjand University of Medical Sciences, Birjand, 9717853577, Iran
4 Department of Health Assistant, Shiraz University of Medical Sciences, Shiraz, 7134814336, Iran
5 Social Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand, 32048321, Iran

* Corresponding Author: Hamid Salehiniya, email

Oncology Research 2023, 31(5), 667-675. https://doi.org/10.32604/or.2023.028406

Abstract

Liquid biopsy, including both circulating tumor cells and circulating tumor DNA, is becoming more popular as a diagnostic tool in the clinical management of breast cancer. Elevated concentrations of these biomarkers during cancer treatment may be used as markers for cancer progression as well as to understand the mechanisms underlying metastasis and treatment resistance. Thus, these circulating markers serve as tools for cancer assessing and monitoring through a simple, non-invasive blood draw. However, despite several study results currently noting a potential clinical impact of ctDNA mutation tracking, the method is not used clinically in cancer diagnosis among patients and more studies are required to confirm it. This review focuses on understanding circulating tumor biomarkers, especially in breast cancer.

Graphical Abstract

Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring

Keywords


Cite This Article

APA Style
ALEMZADEH, E., ALLAHQOLI, L., DEHGHAN, H., MAZIDIMORADI, A., GHASEMPOUR, A. et al. (2023). Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring. Oncology Research, 31(5), 667-675. https://doi.org/10.32604/or.2023.028406
Vancouver Style
ALEMZADEH E, ALLAHQOLI L, DEHGHAN H, MAZIDIMORADI A, GHASEMPOUR A, SALEHINIYA H. Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring. Oncol Res. 2023;31(5):667-675 https://doi.org/10.32604/or.2023.028406
IEEE Style
E. ALEMZADEH, L. ALLAHQOLI, H. DEHGHAN, A. MAZIDIMORADI, A. GHASEMPOUR, and H. SALEHINIYA "Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring," Oncol. Res., vol. 31, no. 5, pp. 667-675. 2023. https://doi.org/10.32604/or.2023.028406



cc This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 1251

    View

  • 382

    Download

  • 2

    Like

Share Link